Dr. Ohlfest is an active member of the American Society of Gene Therapy (ASGT). National Institutes of Health awarded Dr. Ohlfest with the NIH Cancer Biology Training Grant from 2002 - 2004.
Dr. Ohlfest’s Ph.D. research experience focused on developing plasmid-based vectors for gene therapy. In these studies, mouse models of glioblastoma and Hemophilia A were treated providing proof of principle that non-viral vectors show promise for application to human gene therapy.
What's Inside | ||
